All tenders
75A50126F61002
RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1
Office of Assistant Secretary for Preparedness and Response · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50126F61002
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1
- Source
- USASpending (Federal)
- Source ID
- usa-75A50126F61002
Details
- Location
- United States
Description
RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1 Awarded to: LOVELACE BIOMEDICAL RESEARCH INSTITUTE Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DELIVERY ORDER
Dates
- Publication
- 2026/08/26 12:00:00 AM UTC
- Closing date
- 2028/04/25 12:00:00 AM UTC
Estimated value
$3.7M USD
Classification
Normalized category
Healthcare & Medical